scholarly journals Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors

Cancer ◽  
2009 ◽  
Vol 115 (3) ◽  
pp. 655-664 ◽  
Author(s):  
Lisa M. McGregor ◽  
Sheri L. Spunt ◽  
Victor M. Santana ◽  
Clinton F. Stewart ◽  
Deborah A. Ward ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Pediatric Patients ◽  
Phase 1 ◽  
Phase 1 Study

Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 10052-10052 ◽  
Author(s):  
Holly Jane Meany ◽  
Jeffrey Dome ◽  
Pamela S. Hinds ◽  
Rochelle Bagatell ◽  
Suzanne Shusterman ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Pediatric Patients ◽  
Phase 1 ◽  
Phase 1 Study

A Phase 1 Study of ABT-751, an Orally Bioavailable Tubulin Inhibitor, Administered Daily for 7 Days Every 21 Days in Pediatric Patients with Solid Tumors

2006 ◽  
Vol 12 (16) ◽  
pp. 4882-4887 ◽  
Author(s):  
Elizabeth Fox ◽  
John M. Maris ◽  
Brigitte C. Widemann ◽  
Kysa Meek ◽  
Anne Goodwin ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Pediatric Patients ◽  
Phase 1 ◽  
Phase 1 Study ◽  
Tubulin Inhibitor ◽  
Orally Bioavailable

scholarly journals Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors

Cancer ◽  
2009 ◽  
Vol 115 (8) ◽  
pp. 1765-1775 ◽  
Author(s):  
Lisa M. McGregor ◽  
Sheri L. Spunt ◽  
Wayne L. Furman ◽  
Clinton F. Stewart ◽  
Paula Schaiquevich ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Pediatric Patients ◽  
Phase 1 ◽  
Phase 1 Study

scholarly journals A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors

Oncotarget ◽  
2016 ◽  
Vol 7 (51) ◽  
pp. 84736-84747 ◽  
Author(s):  
Andrew D.J. Pearson ◽  
Sara M. Federico ◽  
Isabelle Aerts ◽  
Darren R. Hargrave ◽  
Steven G. DuBois ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Pediatric Patients ◽  
Phase 1 ◽  
Advanced Solid Tumors ◽  
Phase 1 Study

Phase 1 study of olaratumab as monotherapy and in combination with doxorubicin, vincristine/irinotecan, or high-dose ifosfamide in pediatric patients with relapsed or refractory solid tumors: Part A results.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 10541-10541
Author(s):  
Steven G. DuBois ◽  
Brenda Weigel ◽  
Theodore Willis Laetsch ◽  
Margaret Macy ◽  
Donna Elise Levy ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Pediatric Patients ◽  
Phase 1 ◽  
High Dose ◽  
Phase 1 Study

Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors

2021 ◽  
Author(s):  
Holly J. Meany ◽  
Brigitte C. Widemann ◽  
Pamela S. Hinds ◽  
Rochelle Bagatell ◽  
Suzanne Shusterman ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Pediatric Patients ◽  
Phase 1 ◽  
Phase 1 Study
Sign in / Sign up

Export Citation Format

Share Document